Table 3.
Multidimensional classification of patients into low risk and high risk of recurrence and death due to specific RCC.
| AE | AP | Stat. test | P-value | LR | HR |
|---|---|---|---|---|---|
| Recurrence | T | W=333 | <0.0001 | 1b | 3a |
| PLT [thous/μL] | t=−4.2539 | <0.0001 | 231.5 | 278.9 | |
| Na [mmol/L] | t=4.6661 | <0.0001 | 143.4 | 140.6 | |
| OR | W=7694 | <0.0001 | 2.8% | 19.2% | |
| Death | T | W=7691 | <0.0001 | 2a | 3a |
| M | W=5236 | <0.0001 | 0.0% | 20.5% | |
| CREA [μmol/L] | t=−4.2098 | <0.0001 | 85.6 | 97.9 | |
| PLT [thous/μL] | t=5.4487 | <0.0001 | 227.0 | 299.5 | |
| OR | W=5654 | <0.0001 | 10.9% | 41.1% |
AE – adverse event; AP – analyzed parameters; OR – odds ratio; T – tumor scale; PLT – platelets count; Na – preoperative sodium concentration; LR – low risk; HR – high risk; CREA – preoperative creatinine concentration.